Sinopharm Tech Holdings Limited risk profile
65 Stretched several inputs deteriorating together
Measured 21 October 2026 from 8156.HK's filed statements. Recomputed nightly.
65 (Stretched), driven by Cash conversion at 100, over 4 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 72 | Stretched | Stable | Drawdown from the 52-week high — 37.1% |
| Operating pressure | 19 | Contained | Worsening | Costs outgrowing revenue — -5.6 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.36x |
| Leverage and coverage | 99 | Acute | Stable | Net debt to EBITDA — 14.18x |
| Competitive position | Reads research_and_development, operating_income, revenue, peer cohort and disclosed transition KPIs. No reading is stored for this company. | |||
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Technology companies with a risk reading
NVIDIA Corp 43Apple Inc 47Microsoft Corporation 33Taiwan Semiconductor Manufacturing 17Broadcom Inc 29Micron Technology Inc 42Advanced Micro Devices Inc 29ASML HOLDING 25ASML Holding NV 26Palantir Technologies Inc - Class A 17Intel Corp 54Cisco Systems Inc 57
Financials, valuation and price history for Sinopharm Tech Holdings Limited